Berkeley Catalyst Fund (BCF) logo

Berkeley Catalyst Fund (BCF)

North America, California, United States, San Francisco

Description

Berkeley Catalyst Fund (BCF) is an early-stage venture capital firm deeply rooted in the innovation ecosystem of the University of California, Berkeley. Established with a mission to commercialize groundbreaking research and technologies emerging from UC Berkeley and the broader Bay Area, BCF serves as a crucial bridge between academic discovery and market-ready solutions. The firm leverages its unique affiliation with one of the world's leading public universities, providing portfolio companies with unparalleled access to a vast network of faculty, alumni, and scientific expertise, alongside strategic capital.

BCF primarily targets seed and Series A stage companies that are developing disruptive technologies in sectors such as deep tech, life sciences, advanced materials, cleantech, and artificial intelligence. They seek ventures that possess strong intellectual property, a clear path to commercialization, and a passionate founding team. The fund's investment thesis centers on identifying and nurturing companies that can address significant market needs with science-backed innovations, often stemming directly from university labs. Their hands-on approach extends beyond capital, offering strategic guidance, operational support, and connections to industry leaders.

The firm typically deploys initial investments ranging from $250,000 to $1,000,000, demonstrating their commitment to supporting nascent ventures at critical junctures. With a reported fund size for BCF II around $50 million, they possess the capacity for follow-on investments to support portfolio companies through subsequent growth stages. BCF's strategy emphasizes long-term partnerships, aiming to help founders navigate the complexities of scaling deep technology companies from concept to market leadership. Their focus on the Berkeley ecosystem ensures a pipeline of high-potential, research-driven startups poised for significant impact.

Investor Profile

Berkeley Catalyst Fund (BCF) has backed more than 37 startups, with 1 new investments in the last 12 months alone. The firm has led 9 rounds, about 24% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Ireland.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $250K – $1M.

Stage Focus

  • Series A (32%)
  • Seed (27%)
  • Series B (19%)
  • Series Unknown (11%)
  • Series C (5%)
  • Pre Seed (3%)
  • Debt Financing (3%)

Country Focus

  • United States (97%)
  • Ireland (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Medical Device
  • Manufacturing
  • Therapeutics
  • Genetics
  • Information Technology
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Berkeley Catalyst Fund (BCF) frequently co-invest with?

DOV Management
North America, New York, United States, New York
Co-Investments: 3
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 3
SC
North America, California, United States, Palo Alto
Co-Investments: 4
Cowin Venture
Asia, Beijing, China, Beijing
Co-Investments: 3
Agilent Technologies
North America, California, United States, Santa Clara
Co-Investments: 3
Syensqo Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 3
Photon Fund
Asia, Guangdong, China, Shenzhen
Co-Investments: 4
Danfoss Ventures
Europe, Syddanmark, Denmark, Nordborg
Co-Investments: 2
BV
North America, California, United States, Palo Alto
Co-Investments: 4

Which angels does Berkeley Catalyst Fund (BCF) often collaborate with?

AB
North America, California, United States, San Francisco
Shared Deals: 1
AH
North America, California, United States, San Francisco
Shared Deals: 1
JF
North America, Illinois, United States, Chicago
Shared Deals: 1
JS
North America, California, United States, Santa Barbara
Shared Deals: 1
MR
North America, California, United States, San Diego
Shared Deals: 1
CJ
North America, United States
Shared Deals: 1
MD
North America, Wisconsin, United States, Milwaukee
Shared Deals: 1

What are some of recent deals done by Berkeley Catalyst Fund (BCF)?

WaHa

Fremont, California, United States

Revolutionary platform for solid desiccant regeneration improves energy efficiency and carbon emissions by 50% for HVAC and AWG applications

AgTechCleanTechHeating, Ventilation, and Air Conditioning (HVAC)Water
Series AJul 10, 2025
Amount Raised: $8,000,000
Arima Genomics

San Diego, California, United States

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

BiotechnologyHealth CareLife ScienceMedical
Series CJun 17, 2025
Amount Raised: $22,000,000
Bone Health Technologies

San Francisco, California, United States

Bone Health Technologies is developing a new standard of care for treating both osteoporosis and osteopenia, the precursor to osteoporosis.

Health CareMedicalMedical Device
Series UnknownMar 4, 2024
Amount Raised: $5,000,000
Zeda

Fremont, California, United States

Zeda (frmly. PrinterPrezz/Vertex Manufacturing) provides advanced manufacturing services to medical, space, defense, & aerospace industries

3D PrintingManufacturingMedical Device
Series BMar 7, 2023
Amount Raised: $52,000,000
Zeda

Fremont, California, United States

Zeda (frmly. PrinterPrezz/Vertex Manufacturing) provides advanced manufacturing services to medical, space, defense, & aerospace industries

3D PrintingManufacturingMedical Device
Debt FinancingMar 7, 2023
Amount Raised: $16,000,000
Telesair

Irvine, California, United States

Telesair is a medical device company developing respiratory care solutions.

Health CareMedicalMedical Device
Series AJan 10, 2023
Amount Raised: $22,000,000
Valitor

Berkeley, California, United States

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

BiotechnologyDeveloper ToolsMedicalTherapeutics
Series BOct 5, 2022
Amount Raised: $28,000,000
Vicinitas Therapeutics

San Francisco, California, United States

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

BiotechnologyLife ScienceTherapeutics
Series AJul 28, 2022
Amount Raised: $65,000,000
Applaud Medical

San Francisco, California, United States

Applaud Medical is a clinical-stage company that develops a treatment for kidney stones.

Health CareHealth DiagnosticsMedicalMedical Device
Series UnknownJul 27, 2022
Amount Raised: $5,709,998
Arima Genomics

San Diego, California, United States

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

BiotechnologyHealth CareLife ScienceMedical
Series BMar 15, 2022
Amount Raised: $7,000,000